Fisher & Paykel Healthcare Corporation Limited
업데이트됨

$FPH:ASX - FISHER & PAYKEL HEALTHCARE - Entry on pullback?

342
Fisher and Paykel have been having a great run so far this year up around 60% since the start of the year and not much sign of slowing down. The RSI is WAY overextended so I'm hoping that there might be a bit of a pullback / consolidation period allowing us to buy at better value before it continues so I have set an alert for when the RSI gets back to under 70 and see what happens then. Could be worth a watch.

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The Company's segments include New Zealand, which includes all activities controlled by entities or employees based in New Zealand; North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong. Its products include respiratory humidifiers, single-use and reusable chambers and breathing circuits, infant resuscitators, infant warmers and accessories. In addition, the Company offers hardware and consumables.
노트
Nice continuation of trend. RSI pointing up so hopefully will continue its run after minor pullback.

스냅샷
노트
Bit more info on its bounce.

스냅샷
노트
Slow and steady - up 16% from when first spotted.

스냅샷
노트
Up over $25 and continues to shrug off the market volatility.

스냅샷
노트
Got a bit wobbly - would have needed a 20% trail to stay in. Back pushing the $35 mark again.

스냅샷
노트
Feeling a bit flat across the top so will tighten trail.

스냅샷

면책사항

해당 정보와 게시물은 금융, 투자, 트레이딩 또는 기타 유형의 조언이나 권장 사항으로 간주되지 않으며, 트레이딩뷰에서 제공하거나 보증하는 것이 아닙니다. 자세한 내용은 이용 약관을 참조하세요.